AUSTAR PHARMACEUTICAL SYSTEMS (HONG KONG) LIMITED

Yes. AUSTAR PHARMACEUTICAL SYSTEMS (HONG KONG) LIMITED is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2006-09-27 (operating for 20 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: October 2026).

The statutory primary identifiers for AUSTAR PHARMACEUTICAL SYSTEMS (HONG KONG) LIMITED are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [37216915] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [1076854] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

Yes. According to the official statutory records of the Hong Kong Companies Registry, AUSTAR PHARMACEUTICAL SYSTEMS (HONG KONG) LIMITED has officially recorded 1 legal name change(s): [STERIS-AUSTAR Pharmaceutical Systems Hong Kong Limited (思泰瑞奧星製藥設備有限公司) (effective 2006-09-27)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Yes. Statutory indexing confirms that AUSTAR PHARMACEUTICAL SYSTEMS (HONG KONG) LIMITED has accumulated 30 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2026-09-28: Form NAR1 - Annual Return (2026) (English)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Cross-referenced across Hong Kong statutory regulatory registers (including HKMA, SFC, Companies Registry TCSP, Customs MSO/DPMS, and Insurance Authority IA), this entity holds no special statutory financial licence, operating as a general commercial corporation; 2. Judicial Screening (Litigation & Winding-Up): public court records screening identified 1 public court docket(s) associated with this corporation; confirmed no compulsory winding-up petitions (HCCW) on file. Specific court levels (High Court HCA / District Court DCCJ), case numbers, party capacities, and judgments are accessible via official Due Diligence Reports.

The statutory registered office of AUSTAR PHARMACEUTICAL SYSTEMS (HONG KONG) LIMITED on official record is situated at: [ROOM 6, 1/F, BLOCK B, NEW TRADE PLAZA, 6 ON PING STREET, SHA TIN, NEW TERRITORIES, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.